BERKELEY, Calif., Nov. 10, 2011 (GLOBE NEWSWIRE) -- XOMA Ltd. (Nasdaq:XOMA), a leader in the discovery and development of antibody therapeutics, announced that John Varian, Interim Chief Executive Officer, and Paul Rubin, M.D., Vice President, Clinical Development and Chief Medical Officer, will present on behalf of the Company at the Eighth Annual Lazard Capital Markets Healthcare Conference in New York City on Tuesday, November 15, 2011 at 1:00 p.m. Eastern time.
